Clinical and molecular spectrum of a large Egyptian cohort with ALS2‐related disorders of infantile‐onset of clinical continuum IAHSP/JPLS

• Published in: Clinical genetics Vol. 104; no. 2; pp. 238 - 244
• Main Authors: Zaki, Maha S., Sharaf‐Eldin, Wessam E., Rafat, Karima, Elbendary, Hasnaa M., Kamel, Mona, Elkhateeb, Nour, Noureldeen, Mahmoud M., Abdeltawab, Mohamed A., Sadek, Abdelrahim A., Essawi, Mona L., Lau, Tracy, Murphy, David, Abdel‐Hamid, Mohamed S., Holuden, Henry, Issa, Mahmoud Y., Gleeson, Joseph G.
• Format: Journal Article
• Language: English
• Published: Oxford, UK Blackwell Publishing Ltd 01.08.2023
• Subjects: ALS2; Genotypes; IAHSP; JPLS; Motor neuron diseases; Paralysis; Phenotypes; UMNL; UMNL; ALS2; IAHSP; JPLS
• ISSN: 0009-9163; 1399-0004
• DOI: 10.1111/cge.14338

This study presents 46 patients from 23 unrelated Egyptian families with ALS2‐related disorders without evidence of lower motor neuron involvement. Age at onset ranged from 10 months to 2.5 years, featuring progressive upper motor neuron signs. Detailed clinical phenotypes demonstrated inter‐ and intrafamilial variability. We identified 16 homozygous disease‐causing ALS2 variants; sorted as splice‐site, missense, frameshift, nonsense and in‐frame in eight, seven, four, three, and one families, respectively. Seven of these variants were novel, expanding the mutational spectrum of the ALS2 gene. As expected, clinical severity was positively correlated with disease onset (p = 0.004). This work provides clinical and molecular profiles of a large single ethnic cohort of patients with ALS2 mutations, and suggests that infantile ascending hereditary spastic paralysis (IAHSP) and juvenile primary lateral sclerosis (JPLS) are belonged to one entity with no phenotype–genotype correlation.